Positions

Position Company Period
Director Oscient Pharmaceuticals Corp March 19, 2003 -
Independent Trustee Tekla Life Sciences Investors Jan. 1, 2010 -
Independent Trustee Tekla Healthcare Investors June 8, 2010 -
Independent Trustee Tekla World Healthcare Fund Jan. 1, 2015 -
Independent Trustees Tekla Healthcare Opportunities Fund Jan. 1, 2014 -
Lead Independent Director Idera Pharmaceuticals Inc Sept. 1, 2010 - March 10, 2019
Independent Director Madrigal Pharmaceuticals Inc Aug. 1, 2004 - July 22, 2016
William Reardon's trades of Tekla World Healthcare Fund's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-03-01 2021-02-25
B Purchase
1,460 +inf%
17.14
USD 25,024 		1,460 +inf% 17.14 USD 25,024
2021-03-01 2021-02-25
B Purchase
1,196 +inf%
20.85
USD 24,937 		1,196 +inf% 20.85 USD 24,937
2014-07-01 2014-06-30
B Purchase
200 +14.2%
19.75
USD 3,950 		200 +14.2% 19.75 USD 3,950
2013-11-15 2013-11-13
B Purchase
13,333 +57.4%
3.75
USD 49,999 		13,333 +57.4% 3.75 USD 49,999
2012-03-12 2012-03-09
B Purchase
646 +inf%
15.86
USD 10,242 		646 +inf% 15.86 USD 10,242
2012-03-12 2012-03-09
B Purchase
772 +inf%
13.27
USD 10,241 		772 +inf% 13.27 USD 10,241
2004-07-12 2004-07-08
B Purchase
5,974 +115.8%
0.54
USD 3,250 		5,974 +115.8% 0.54 USD 3,250
// ... existing code ... // ... rest of the file ...